INSIDER · CIK 1706399
Chimovits Erez
Director at ADARx Pharmaceuticals, Inc. (ADRX) · Director, 10% Owner at Braveheart Bio, Inc. (BRVE)
↗4 Form 4 rows in the window
Covers original filings from Aug 1, 2026 to Oct 29, 2026. Older trades and amendments are in the SEC history.
$36.0MBought on the market
$0.00Sold on the market
2Companies
Sep 30, 2026Latest filing
| Company | Title | Type | Owned | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Sep 30, 202617:29 | Sep 28, 2026 | ADRXADARx Pharmaceuticals, Inc. | Director | P · Buy | $17.00 | +61,516 | 9,292,025 | +1% | +$1.0M | -12.1% | +5.0% |
| Sep 30, 202617:29 | Sep 28, 2026 | ADRXADARx Pharmaceuticals, Inc. | Director | C · Convert | — | +9,230,509 | 9,230,509 | New | — | ||
| Aug 11, 202617:31 | Aug 7, 2026 | BRVEBraveheart Bio, Inc. | Director, 10% Owner | P · Buy | $18.00 | +1,940,000 | 273,333 | — | +$34.9M | -39.6% | +17.7% |
| Aug 11, 202617:31 | Aug 7, 2026 | BRVEBraveheart Bio, Inc. | Director, 10% Owner | C · Convert | — | +9,132,420 | 10,235,159 | +828% | — |